Skip to content

DR. INGE SCHOEFS

Active
Private limited companyfounded 2011active for 14 yearsOude Berg 7B, 3840 Tongeren-Borgloon, BelgiumKBO/BCE: BE 0842.114.903
Summary

DR. INGE SCHOEFS has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €328,406 and a net result of €74,349. Equity has been growing by about 17% per year since 2019. Its solvency ranks better than 84% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 23-12-2011 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.205.683.295 3840 Tongeren-Borgloon, since 23-12-2011
Financial year end
30 June
Peppol
Reachable since 28-07-2024

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€98,501
▲ 14.7%
Turnover
≈ €220,000
estimated
Profit
€74,349
▲ 20.5%
Equity
€328,406
▲ 9.3%
Total assets
€363,927
▲ 9.3%
Filed on 03-12-2025, 59 days before the deadline
Score breakdownlowers riskLiquidity: current ratio 10.05, cash €333,418Sector: Human health activities (NACE 86)Equity €328,406 (90.2% of total assets)Size: total assets €363,927Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 70% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 90.2% of total assets
Liquidity 100=
short-term debt 9.8% · cash 91.6%
Profitability 94+2
return on assets 20.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024highest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 10.05 (10.01 in 2024), above the usual 1.5. Short-term debt is 9.8% and cash 91.6% of total assets. 9.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 53% on profitability and 51% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 10.05, cash €333,418
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €328,406 (90.2% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €363,927
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 03-12-2025, 59 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
59 days early
2024
28 days early
2023
41 days early
2022
49 days early
2021
55 days early
2020
54 days early
2019
50 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 48 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 13 December (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end01-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 84% of companies in human healthsector median 63.0% · 20,678 companies 90.2% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €74,349 7 years View

Recent changes

  1. · Gazette deed Resignation: SCHOEFS Inge Marcella Alice (director)Reappointment: SCHOEFS Inge Marcella Alice (director)
  2. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as DR. INGE SCHOEFS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €307,000 and €393,000, founded between 2009 and 2013.

CompanyTotal assetsGross margin
DR. INGE SCHOEFS Tongeren-Borgloon€363,927€98,501
DR. M. VRIJENS Hasselt€388,165€103,701
Dr. Christian Warson Diepenbeek€365,584€99,725
Dr. Greet Mentens Lommel€306,669€98,596
DOCTEUR PHILIPPE LEONARD Jette€373,371€97,008
SEURINCK ALEXANDER HUISARTS Kortrijk€392,714€99,682
Docteur GOVAERTS Hilde Plombières€346,726€94,027
Full comparison

Key facts about DR. INGE SCHOEFS

What is the company number of DR. INGE SCHOEFS?
The company number of DR. INGE SCHOEFS is 0842.114.903. The VAT number is the same number with BE in front: BE 0842.114.903.
Where is DR. INGE SCHOEFS based?
The registered office is at Oude Berg 7B, 3840 Tongeren-Borgloon.Company details
What does DR. INGE SCHOEFS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. INGE SCHOEFS?
The legal form of DR. INGE SCHOEFS is Private limited company (BV).
When was DR. INGE SCHOEFS founded?
DR. INGE SCHOEFS was founded on 23-12-2011.
Is DR. INGE SCHOEFS still active?
Yes, DR. INGE SCHOEFS is an active enterprise in the KBO register.
What is the turnover of DR. INGE SCHOEFS?
The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €98,501 and 32 comparable companies (NACE 862). It probably lies between €170,000 and €280,000.Financials
Is DR. INGE SCHOEFS profitable?
In financial year 2025, DR. INGE SCHOEFS made a profit of €74,349.
Where can I find the annual accounts of DR. INGE SCHOEFS?
DR. INGE SCHOEFS filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. INGE SCHOEFS due?
DR. INGE SCHOEFS must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.